OOIR: Observatory of International Research

Papers

(The H4-Index of Translational Oncology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Global colorectal cancer burden in 2020 and projections to 2040	871
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview	439
Resistance to Checkpoint Inhibition in Cancer Immunotherapy	166
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis	120
Early lung cancer diagnostic biomarker discovery by machine learning methods	95
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis	92
3D Bioprinted cancer models: Revolutionizing personalized cancer therapy	88
Plasticity of cancer cell invasion: Patterns and mechanisms	78
The interaction mechanism between autophagy and apoptosis in colon cancer	77
Influence of cholesterol on cancer progression and therapy	64
Extracellular heat shock proteins and cancer: New perspectives	57
The remodelling of actin composition as a hallmark of cancer	55
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles	55
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases	54
Prognostic Indicators for Gastrointestinal Stromal Tumors: A Review	50
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis	49
Regulation of CD47 expression in cancer cells	47
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?	45
Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer	43
Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response	40
PLK1 inhibition-based combination therapies for cancer management	40
Drug screening model meets cancer organoid technology	36
Choosing The Right Animal Model for Renal Cancer Research	35
Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma	35
Combination therapy: Future directions of immunotherapy in small cell lung cancer	34

The spontaneous remission of cancer: Current insights and therapeutic significance	34
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion	34
Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma	34
Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes	34
S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study	34
Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials	33
Resistin: A journey from metabolism to cancer	33
Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer	33
Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images	33